Physician profile
William David Boothe
NPI 1649711904
$3,188.30
in general payments reported to CMS, 2019-2025
21 companies · $168 in 2025
The $168 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $272 · 2020: $315 · 2021: $1,409 · 2022: $735 · 2023: $178 · 2024: $111 · 2025: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $457.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $456.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,076.66 | 2020-2025 | Otezla |
| Lilly USA, LLC | $436.93 | 2019-2021 | |
| Leo Pharma INC. | $318.04 | 2022-2024 | Adbry |
| Sun Pharmaceutical Industries INC. | $288.12 | 2019-2022 | |
| Abbvie INC. | $277.33 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $246.44 | 2021-2025 | Dupixent |
| Celgene Corporation | $106.62 | 2019 | |
| Janssen Biotech, INC. | $98.45 | 2019-2025 | Tremfya |
| Kerecis Limited | $83.66 | 2022 | |
| Krystal Biotech INC | $29.39 | 2025 | Vyjuvek |
| Pfizer INC. | $27.73 | 2022 | |
| Biofrontera INC. | $24.96 | 2019 | |
| Genentech USA, INC. | $24.72 | 2020 | |
| Tactile Systems Technology INC | $24.68 | 2021-2022 | |
| Organon LLC | $23.08 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $20.96 | 2025 | Sotyktu |
| Novartis Pharmaceuticals Corporation | $19.83 | 2025 | |
| Kyowa Kirin, INC. | $18.31 | 2020 | |
| Genzyme Corporation | $17.37 | 2021 | |
| Alnylam Pharmaceuticals INC. | $13.65 | 2021 | |
| Galderma Laboratories, L.P. | $11.37 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Boothe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.